Hjem › Neuroblastom › North Carolina › Durham
Kliniske studier for Neuroblastom i Durham, NC
6 studier for Neuroblastom søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekruttererFase 2
- Duke University, Durham
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- Duke University, Durham
SPEARHEAD-3 Pediatric Study
RekruttererFase 1/2
- Duke University School of Medicine, Durham
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
RekruttererFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi unna
Neuroblastom-studier i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- Dallas, TX9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
Andre studier i Durham
- Brystkreft63 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Metastatisk kreft33 studier
- Akut myelogen leukemi33 studier
- Lungekreft32 studier
- Prostatakreft32 studier
- Kolorektal kreft28 studier
- Kronisk lymfatisk leukemi27 studier
- Eggstokkreft27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.